Trial Profile
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 19 Oct 2012
Price :
$35
*
At a glance
- Drugs Arundic acid (Primary)
- Indications Stroke
- Focus Registrational; Therapeutic Use
- 10 Oct 2012 Actual end date (May 2005) added as reported by ClinicalTrials.gov.
- 12 Jun 2012 Planned number of patients (1320) added as reported by ClinicalTrials.gov..
- 12 Jun 2012 Additional lead trial investigator (Bryan Due) identified as reported by ClinicalTrials.gov.